SEC Comment Letter 0000000000-24-006368 to Structure Therapeutics Inc. (GPCR) (CIK 0001888886) (GPCR)
Structure Therapeutics Inc. (GPCR) (CIK 0001888886)
Date: June 4, 2024 · CIK: 0001888886 · Accession: 0000000000-24-006368
AI Filing Summary & Sentiment
File numbers found in text: 001-41608
Letter
United States securities and exchange commission logo June 4, 2024 Jun Yoon Chief Financial Officer Structure Therapeutics Inc. 601 Gateway Blvd., Suite 900 South San Francisco, California Re:Structure Therapeutics Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-41608 Dear Jun Yoon: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
June 4, 2024
Jun Yoon
Chief Financial Officer
Structure Therapeutics Inc.
601 Gateway Blvd., Suite 900
South San Francisco, California
94080
Re:Structure Therapeutics Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-41608
Dear Jun Yoon:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences